戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 564作成日:2026年10月23日

2-Bromoanisole → Tert-butyl 4-(2-methoxyphenyl)piperazine-1-carboxylate

https://huagongshe.com/ja/reaction/564

反応式

関与物質

役割名称HCID仕込み量
反応物2-BromoanisoleHCID 11358—
反応物tert-Butyl piperazine-1-carboxylateHCID 143452—
試薬Sodium t-butoxideHCID 23676156—
触媒Binap, (A+-)-HCID 634876—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒TolueneHCID 1140—
生成物Tert-butyl 4-(2-methoxyphenyl)piperazine-1-carboxylateHCID 1356054862.37%

反応条件

温度100 °C

反応手順

TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.059 g, 0.06 mmol) and 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.080 g, 0.13 mmol) were mixed in toluene (10 mL) and degessed at 90 °C for 10 mins. The mixture was then cooled and 1-bromo-2-methoxybenzene (0.400 mL, 3.21 mmol), sodium 2-methylpropan-2-olate (0.493 g, 5.13 mmol) and tert-butyl piperazine-1-carboxylate (0.597 g, 3.21 mmol) were added. The resulting mixture was stirred at 100 °C for 16 hours under nitrogen. The reaction mixture was filtered through celite and the filtrate concentrated. The crude product was purified by flash silica chromatography, elution gradient 20 to 100% EtOAc in heptane. Pure fractions were evaporated to dryness to afford tert-butyl 4-(2-methoxyphenyl)piperazine-1-carboxylate (0.585 g, 62.4 %) as a yellow oil which crystallised on standing.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-636da506499347d7aba99b6e3204f5ba
出典メモ750 AstraZeneca ELN dataset